Status:
COMPLETED
Evaluation of Pharmacist's Intervention in Improving Treatment Outcomes of Rheumatoid Arthritis: A Randomized Controlled Trial
Lead Sponsor:
Universiti Sains Malaysia
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rheumatoid arthritis is an auto-immune disorders that mainly affects the joints. It may also affect other organs of the body such as skin, eyes, lungs and heart. The immune system of the body attacks ...
Detailed Description
One of the major problems in managing RA is adherence to rehabilitation and medication. Studies report low adherence to medication among patients of RA. Certain barriers to rehabilitation also exists ...
Eligibility Criteria
Inclusion
- Out-patients with established diagnosis of rheumatoid arthritis over 3 months.
- Participants who are willing to participate in the study.
Exclusion
- Patients with no rheumatoid arthritis.
- Patients currently undergoing surgery or had previous history of surgery.
- Patients with more than 3 comorbidities.
- Patients who are not willing to participate.
- In-patients will not be included.
Key Trial Info
Start Date :
December 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 17 2018
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03254745
Start Date
December 19 2017
End Date
August 17 2018
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clifton Central Hospital
Karachi, Sindh, Pakistan, 75600